Do you want to read an article? Please log in or register.
Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trial
Type 2 Diabetes
COMMENTED
Related content
Diabetes - GeneralType 1 Diabetes
Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial
Lancet Diabetes Endocrinol.
van Beers CA, DeVries JH, Kleijer SJ, Smits MM, Geelhoed-Duijvestijn PH, Kramer MH, Diamant M, Snoek FJ, Serné EH
doi: 10.1016/
Type 2 DiabetesGlycemic Control
Temporal changes in the incidence and predictors of severe hypoglycaemia in type 2 diabetes: The Fremantle Diabetes Study
Diabetes Obes Metab.
Davis TME, Bruce DG, Finn J, Curtis BH, Barraclough H, Davis WA
doi: 10.1111/dom.13568.
COMMENTED
Type 2 Diabetes
Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet Neurol.
Cukierman-Yaffe T, Gerstein HC, Colhoun HM, Diaz R, García-Pérez LE, Lakshmanan M, Bethel A, Xavier D, Probstfield J, Riddle MC, Rydén L, Atisso CM, Hall S, Rao-Melacini P, Basile J, Cushman WC, Franek E, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T
doi: 10.1016/S1474-4422(20)30173-3.
Diabetes - GeneralType 1 Diabetes
Cognitive deficits associated with impaired awareness of hypoglycaemia in type 1 diabetes
Diabetologia.
Hansen TI, Olsen SE, Haferstrom EC, Sand T, Frier BM, Håberg AK, Bjørgaas MR
doi: 10.1007/s00125-017-4233-3.
Diabetes - GeneralType 2 Diabetes
Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial
Lancet Diabetes Endocrinol.
Parvanova A, Trillini M, Podestà MA, Iliev IP, Ruggiero B, Abbate M, Perna A, Peraro F, Diadei O, Rubis N, Gaspari F, Carrara F, Stucchi N, Belviso A, Bossi AC, Trevisan R, Remuzzi G, de Borst M, Ruggenenti P; PROCEED Study Organization and the Scientific Writing Academy (SWA) 2016
doi: 10.1016/
COMMENTED
Type 1 Diabetes
Severe Hypoglycemia and Cognitive Function in Older Adults With Type 1 Diabetes: The Study of Longevity in Diabetes (SOLID)
★ 0
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes Care.
Lacy ME, Gilsanz P, Eng C, Beeri MS, Karter AJ, Whitmer RA
doi: 10.2337/dc19-0906.
Diabetes - GeneralType 2 Diabetes
Group cognitive behavioural therapy and weight regain after diet in type 2 diabetes: results from the randomised controlled POWER trial
Diabetologia.
Berk KA, Buijks HIM, Verhoeven AJM, Mulder MT, Özcan B, van 't Spijker A, Timman R, Busschbach JJ, Sijbrands EJ
doi: 10.1007/
COMMENTED
Diabetes - GeneralType 1 DiabetesType 2 DiabetesGlycemic Control
Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia
doi: 10.1007/s00125-017-4449-2.
Type 2 Diabetes
Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial
Diabetologia.
Philis-Tsimikas A, Klonoff DC, Khunti K, Bajaj HS, Leiter LA, Hansen MV, Troelsen LN, Ladelund S, Heller S, Pieber TR, CONCLUDE Study Group.
doi: 10.1007/s00125-019-05080-9.